Neurology Minute

In the September episode of the President's Spotlight, Dr. Jason Crowell and Dr. Natalia Rost highlight this year's AAN Brain Health Summit and discuss the events taking place.  Show reference:  https://www.aan.com/about-the-aan/presidents-spotlight  https://www.aan.com/tools-resources/brain-health/brain-health-summit  

In the fourth episode of this series, Dr. Andy Southerland discusses the Capitol Hill Report from August 11th, where AAN members met with their local state representatives to discuss making telehealth flexibilities permanent and reforming prior authorization processes. Stay updated with what’s happening on the hill by visiting aan.com/chr.  Learn how you can get involved with AAN advocacy. 

In the final part of this series, Dr. Jeff Ratliff and Dr. Valtteri Kaasinen discuss how to speak with patients and families when having a conversation about an initial diagnosis of Parkinson disease. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213499  

Dr. Alex Menze and Dr. Christopher J. Klein discuss whether GLP-1RA usage is linked to radiculoplexus neuropathy and common fibular neuropathy.  Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213916   

In part one of this series, Dr. Jeff Ratliff and Dr. Valtteri Kaasinen discuss what this study teaches us about the diagnosis of Parkinson disease once it is given to patients who are subsequently followed over time.  Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213499 

In the final episode of this foundational neurology series, Casey Kozak discusses serotonin syndrome. 

In part four of this foundational neurology series, Casey Kozak explores neuroleptic malignant syndrome and highlights key similarities and differences with malignant hyperthermia. 

In part three of this foundational neurology series, Casey Kozak discusses malignant hyperthermia caused by inhaled anesthetics and depolarizing neuromuscular blockers.   

Dr. Trey Bateman and Dr. David T. Jones discuss how the StateViewer system leverages FDG-PET imaging and machine learning to improve diagnostic accuracy and clinical decision-making for Alzheimer disease and related disorders. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213831 

Dr. Dan Ackerman talks with Dr. Urs Fischer about the optimal timing of anticoagulation after ischemic stroke in patients with atrial fibrillation.  show reference: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00439-8/fulltext  

Dr. Bradley Ong shares early insights from the EMERGE trial, presented at the American Headache Society’s 67th Annual Scientific Meeting in June 2025.  Show reference:  https://headachejournal.onlinelibrary.wiley.com/doi/10.1111/head.14957

In part two of this foundational neurology series, Casey Kozak discusses key differences and clinical implications of subdural hematomas.

In part one of this foundational neurology series, Casey Kozak discusses how to interpret a head CT as well as the clinical presentation of epidural hematomas.   

Drs. Jeff Ratliff, Michael A. Van Es, and Eva de Boer discuss what this study taught us about the value and application of the 2020 consensus criteria for diagnosing primary lateral sclerosis.  Show reference:  https://www.neurology.org/doi/10.1212/WNL.0000000000213461 

Drs. BJ Hicks, Birgitte Hede Ebbesen, and Boris Modrau discuss fatigue following transient ischemic attack and examine the characteristics of patients who experience pathologic fatigue.  Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213605   

In the final episode of this ten-part series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss when and where to use clinical metagenomic next-generation sequencing tests, as well as the limitations of these tests.  Show reference:  https://www.nature.com/articles/s41591-024-03275-1 

In part nine of this ten-part series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss the findings from this study and the implications for global vaccine strategy.  Show reference:  https://pubmed.ncbi.nlm.nih.gov/40086461/     

In part two of this two-part series, Dr. Stacey Clardy and Casey R. Vanderlip discuss the changes that neurologists should implement in their clinics based on the findings from this study regarding APOE genotype.  Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213853  

In part one of this two part series, Dr. Stacey Clardy and Casey R. Vanderlip discuss what neurologists need to know about how APOE4 and amyloid interact to impact cognitive function.  Show reference:  https://www.neurology.org/doi/10.1212/WNL.0000000000213853